Article
Methylenetetrahydrofolate reductase C677T polymorphism and cervical cancer risk: a meta-analysis.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2012
Guo Li-Na
Abstract excerpt
BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in the metabolism of folate, and the role of MTHFR C677T polymorphism in cervical carcinogenesis is still controversial. METHOD: We performed a meta-analysis of all relevant case-control studies that examined any association...
Topics
- Asia
- Case-Control Studies
- Female
- Genetic Predisposition to Disease
- Humans
- Methylenetetrahydrofolate Reductase (NADPH2)
- Polymorphism, Genetic
- Prognosis
- Risk Factors
- Uterine Cervical Neoplasms